The largest database of trusted experimental protocols

Agilent sureselectxt human all exon v4 kit

Manufactured by Agilent Technologies

The Agilent SureSelectXT Human All Exon V4 kit is a targeted enrichment solution for next-generation sequencing (NGS) applications. The kit is designed to capture the complete set of human protein-coding exons, providing a comprehensive coverage of the human exome. The kit includes pre-designed RNA baits that target known exonic regions, enabling efficient and specific enrichment of the human exome from DNA samples.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using agilent sureselectxt human all exon v4 kit

1

Whole Exome Sequencing for Congenital Lymphedema

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole exome sequencing was performed on DNA extracted from whole blood using previously described method with the following alterations: the Agilent SureSelectXT Human All Exon V4 kit (Agilent Technologies) was used29 (link), and sequencing was performed on the HiSeq2500 instrument (Illumina) with 100bp paired-end sequencing. Sequence was aligned to the human reference genome (Hg19) using Burrow-Wheeler Aligner (0.5.11)30 (link); variants were called with Samtools31 (link) and Genome Analysis Toolkit (v.1.6)30 (link) and annotated with Annovar31 (link). Variants with a quality score <10 were excluded from analysis. Variant filtering and segregation was performed with in house developed software (https://github.com/brendanofallon/VarViewer). All genes previously associated with congenital lymphedema (CCBE1, FOXC2, FLT4, KIF11, GATA2, GJC2, SOX18, FAT4 and PTPN14) were specifically analyzed and no rare or pathogenic variants were found in any family member despite full sequencing coverage. The reported PIEZO1 variants were confirmed by Sanger sequencing using standard methods. Primer sequences are available upon request.
+ Open protocol
+ Expand
2

Whole-Exome Sequencing for Congenital Lymphoedema

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-exome sequencing was performed on DNA extracted from whole blood using a previously described method with the following alterations: the Agilent SureSelectXT Human All Exon V4 kit (Agilent Technologies) was used27 (link), and sequencing was performed on the HiSeq2500 instrument (Illumina) with 100-bp paired-end sequencing. Sequence was aligned to the human reference genome (Hg19) using Burrow–Wheeler Aligner (0.5.11)28 (link); variants were called with Samtools29 (link) and Genome Analysis Toolkit (v.1.6)30 (link) and annotated with Annovar31 (link). Variants with a quality score <10 were excluded from analysis. Variant filtering and segregation was performed with in-house developed software (https://github.com/brendanofallon/VarViewer). All genes previously associated with congenital lymphoedema (CCBE1, FOXC2, FLT4, KIF11, GATA2, GJC2, SOX18, FAT4 and PTPN14) were specifically analysed and no rare or pathogenic variants were found in any family member despite full sequencing coverage. The reported PIEZO1 variants were confirmed by Sanger sequencing using standard methods. Primer sequences are available upon request.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!